Good morning :)

Best Pharma Stocks in India 2025

India is ranked 3rd in pharmaceutical production by volume and 14th in terms of value. The industry has grown at a CAGR of 9.43% over the past nine years and contributes around 1.72% to India’s GDP. Here is a list of the leading pharmaceutical companies in India, driving growth and innovation in the sector.

List of Best Pharma Sector Stocks in India (2025)

Pharmaceuticals Stock Screener

Pharmaceuticals Stock Screener: Analyse & Filter Indian Stocks on Tickertape

Created by

@tickertapetickertape

Showing 1 - 20 of 213 results

last updated at 9:45 PM IST 
NameStocks (213)↓↓Sub-SectorSub-Sector↓↓Market CapMarket Cap↓↓Close PriceClose Price↓↓PE RatioPE Ratio↓↓1D Return1D Return↓↓1M Return1M Return↓↓6M Return6M Return↓↓1Y Return1Y Return↓↓PB RatioPB Ratio↓↓Return on EquityReturn on Equity↓↓ROCEROCE↓↓Dividend YieldDiv Yield↓↓Debt to EquityDebt to Equity↓↓Volatility vs NiftyVolatility vs Nifty↓
1.Sun Pharmaceutical Industries LtdSUNPHARMAPharmaceuticalsPharmaceuticals4,30,320.734,30,320.731,793.501,793.5039.3739.37-0.76-0.765.295.296.296.29-0.66-0.665.945.9415.6615.6618.9718.970.890.890.030.031.601.60
2.Torrent Pharmaceuticals LtdTORNTPHARMPharmaceuticalsPharmaceuticals1,28,321.591,28,321.593,791.503,791.5067.1467.14-0.20-0.20-0.58-0.5816.3516.3513.9313.9316.9116.9126.4626.4630.2230.220.840.840.420.421.681.68
3.Cipla LtdCIPLAPharmaceuticalsPharmaceuticals1,22,571.201,22,571.201,517.401,517.4023.2523.250.340.34-0.21-0.210.970.974.984.983.923.9218.1518.1521.6121.611.051.050.010.011.611.61
4.Dr Reddy's Laboratories LtdDRREDDYPharmaceuticalsPharmaceuticals1,06,505.811,06,505.811,279.301,279.3018.8318.830.460.464.664.66-6.12-6.122.722.723.143.1418.1918.1922.7622.760.630.630.140.141.691.69
5.Lupin LtdLUPINPharmaceuticalsPharmaceuticals96,562.7096,562.702,113.902,113.9029.4329.431.541.544.884.884.484.48-0.28-0.285.585.5820.7320.7321.5321.530.570.570.320.322.112.11
6.Zydus Lifesciences LtdZYDUSLIFEPharmaceuticalsPharmaceuticals93,494.2393,494.23929.15929.1520.6620.660.720.72-2.11-2.11-5.07-5.07-4.85-4.853.553.5518.6818.6822.4022.401.181.180.120.121.871.87
7.Mankind Pharma LtdMANKINDPharmaceuticalsPharmaceuticals89,941.9789,941.972,178.802,178.8045.1845.180.550.55-1.84-1.84-8.84-8.84-17.80-17.806.176.1716.4916.4913.4313.43--0.580.582.352.35
8.Aurobindo Pharma LtdAUROPHARMAPharmaceuticalsPharmaceuticals69,411.6069,411.601,195.101,195.1019.9119.911.951.950.850.853.453.45-1.61-1.612.132.1311.1511.1515.8715.87--0.250.252.292.29
9.Alkem Laboratories LtdALKEMPharmaceuticalsPharmaceuticals67,327.0567,327.055,631.005,631.0031.0931.090.090.09-1.24-1.2416.1916.193.603.605.415.4118.7118.7119.2919.290.800.800.110.111.721.72
10.Abbott India LtdABBOTINDIAPharmaceuticalsPharmaceuticals59,519.2959,519.2928,010.0028,010.0042.0842.08-0.69-0.69-4.99-4.99-11.29-11.29-2.57-2.5714.0614.0635.6635.6642.0942.091.701.700.050.051.911.91
11.Glenmark Pharmaceuticals LtdGLENMARKPharmaceuticalsPharmaceuticals55,734.6655,734.661,975.001,975.0053.2353.230.970.977.857.8520.4620.4628.6628.666.306.3012.5412.5416.0216.020.130.130.280.282.502.50
12.Laurus Labs LtdLAURUSLABSPharmaceuticalsPharmaceuticals54,649.6854,649.681,012.301,012.30152.52152.52-0.69-0.693.053.0551.8351.8379.5579.5511.8711.878.228.2212.0812.080.120.120.600.602.722.72
13.GlaxoSmithKline Pharmaceuticals LtdGLAXOPharmaceuticalsPharmaceuticals44,059.1244,059.122,600.802,600.8047.5047.50-0.81-0.815.495.49-21.66-21.6612.8812.8822.5822.5849.7549.7557.2557.252.082.080.010.013.113.11
14.IPCA Laboratories LtdIPCALABPharmaceuticalsPharmaceuticals37,190.5037,190.501,465.901,465.9050.4250.42-0.41-0.4111.9111.915.995.99-6.06-6.064.434.439.169.1613.0313.030.270.270.160.162.762.76
15.Ajanta Pharma LtdAJANTPHARMPharmaceuticalsPharmaceuticals33,230.3833,230.382,659.802,659.8036.1036.100.320.323.403.40-2.58-2.58-6.31-6.318.778.7725.0225.0230.9630.961.061.060.010.012.562.56
16.J B Chemicals and Pharmaceuticals LtdJBCHEPHARMPharmaceuticalsPharmaceuticals28,165.8428,165.841,798.001,798.0042.7042.70-0.98-0.98-0.25-0.253.023.02-2.32-2.328.208.2020.7520.7524.7524.750.860.860.010.012.162.16
17.Gland Pharma LtdGLANDPharmaceuticalsPharmaceuticals27,656.0127,656.011,678.601,678.6039.5939.59-0.79-0.79-9.14-9.140.550.55-5.83-5.833.023.027.827.8211.5011.501.071.070.030.032.132.13
18.Emcure Pharmaceuticals LtdEMCUREPharmaceuticalsPharmaceuticals27,270.8027,270.801,438.601,438.6040.0340.032.082.083.093.094.564.566.926.925.885.8817.5517.5521.0321.030.210.210.220.223.023.02
19.Piramal Pharma LtdPPLPHARMAPharmaceuticalsPharmaceuticals23,070.2823,070.28174.45174.45253.16253.161.551.55-11.74-11.74-12.74-12.74-30.72-30.722.842.841.141.147.177.170.080.080.600.602.862.86
20.Astrazeneca Pharma India LtdASTRAZENPharmaceuticalsPharmaceuticals22,887.5022,887.509,155.009,155.00197.75197.750.090.09-0.02-0.02-10.20-10.2037.6637.6629.7129.7115.6215.6219.3619.360.350.350.050.052.832.83
Edit Filters

Analyse pharmaceutical stocks further

Visit 'Pharmaceutical Stocks' ScreenerScreener

Disclaimer: Please note that the above table is for informational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing. The data is derived from Tickertape Stock Screener and is subject to real-time updates.

Selection criteria: Sub-sector: Pharmaceuticals | Market Cap: Sorted from Highest to Lowest

Overview of Top Pharma Stocks in India

Sun Pharmaceutical Industries Ltd

Founded in 1983, Sun Pharma is one of India’s largest pharmaceutical companies. It makes generic medicines, over-the-counter products, and active ingredients. The company has a strong presence in the U.S. and focuses on treating cancer, heart diseases, and mental health issues.

Torrent Pharmaceuticals Ltd

Founded in 1959, Torrent Pharmaceuticals is one of India’s leading pharma companies. It makes a wide range of generic medicines for heart, brain, and stomach conditions. The company operates in over 40 countries and has a strong presence in the U.S. and Europe.

Cipla Ltd

Founded in 1935, Cipla is a global pharmaceutical company that makes medicines for asthma, cancer, and HIV/AIDS. The company is known for its innovative drugs and has a strong presence in more than 170 countries.

Dr Reddy's Laboratories Ltd

Founded in 1984, Dr Reddy’s Laboratories is one of India’s top pharmaceutical companies. It makes various generic medicines for cancer, heart diseases, and diabetes. The company also produces active ingredients and has a global presence.

Lupin Ltd

Founded in 1968, Lupin is a global pharma company known for its generics and branded medicines for heart, diabetes, and respiratory problems. It is one of the largest suppliers of generics in the U.S. and operates in over 100 countries.

What are Pharma Stocks?

Pharma stocks are shares in companies that create, produce, and sell medicines and healthcare products. These companies can be large global firms making prescription drugs, over-the-counter medications, and vaccines, or smaller biotech companies working on new treatments and medical devices.

How to Invest in Pharma Stocks in India?

Investing in pharma sector stocks in India using Tickertape is a straightforward process. Tickertape is a powerful stock analysis and screening tool that helps you make informed investment decisions. Here’s how you can use Tickertape to invest in pharma sector stocks:

  1. Sign Up and Log In: You can create an account on the Tickertape or log in if you already have one.
  2. Search for Stocks in Pharmaceuticals Industry: Go to Tickertape Stock Screener and search for the ‘Pharmaceuticals’ sector.
  3. Use Filters: You can apply over 200 filters to get stocks sorted based on criteria like market cap, P/E ratio.
  4. Analyse Stock Data: Tickertape provides comprehensive data on each stock, including financials, performance metrics, future projections, red flags, and more. You can review this data to assess each company’s health and potential in depth.
  5. Add to Watchlist: You may keep track of potential investments by adding them to your watchlist.
  6. Invest Through Your Broker: Once you’ve decided on a stock, you can place a buy order through your brokerage account linked to Tickertape.

You can stay updated with each of your favourite stocks’ alerts and announcements with Tickertape Alerts. Further, you can analyse your overall portfolio and potential red flags in it by connecting it to Tickertape. Check out detailed analysis of your portfolio now!

Government Initiatives and Budget Allocations for the Pharmaceutical Sector

  1. Pharmaceutical Exports Expansion: India plans to increase pharmaceutical exports by 20% to markets like Russia, the Netherlands, and Brazil by September 2025, building on existing export destinations such as the U.S., U.K., and Brazil.
  2. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP): By June 2025, the scheme will have 16,912 Jan Aushadhi Kendras, aiming for 25,000 by March 2027. It offers affordable medicines and medical devices, saving citizens ₹ 38,000 cr. and reducing out-of-pocket health spending from 63% in FY15 to 39% in FY22.
  3. Ayushman Bharat Digital Mission (ABDM): Launched to create electronic health records for all citizens, ABDM had over 73.98 cr. Ayushman Bharat Health Accounts (ABHA) by February 2025, with over 3.6 lakh health facilities and 5.6 lakh healthcare professionals onboarded.
  4. National Biopharma Mission: With ₹ 2,142 cr. funding from the World Bank, this mission supports over 101 projects, 150+ organisations, and 30 MSMEs. It has generated over 1,000 jobs and helped establish 11 shared research facilities.
  5. R&D Support: The government is funding pharmaceutical and medical device research under the ₹ 720.97 cr. PRIP scheme, supporting Centres of Excellence at NIPER and private-sector research.
  6. Union Budget 2025-26 Allocations: The Union Budget has raised allocations for the pharmaceutical sector, including ₹ 1,400 cr. to develop three mega bulk drug parks. The overall pharma budget has increased to ₹ 5,268 cr.

Advantages of Investing in the Pharmaceutical Stocks

Steady Market Growth

The Indian pharmaceutical market is expected to reach $193.59 bn by FY32, growing at a rate of 8% annually. India is also the third-largest producer of active pharmaceutical ingredients (APIs), playing a major role in the global supply of medicines.

Export Opportunities

India is the world’s largest supplier of generic drugs, making up 20% of global supply by volume. With pharmaceutical exports worth ₹2,59,658 cr. in FY25, India is well-positioned to meet the growing demand from markets like the U.S., EU, and Japan.

Growing Biosimilars Market

India’s biosimilars market is growing fast, with a projected annual growth rate of 22%. It is expected to reach $12 bn by 2025. This growth is driven by rising demand for affordable biological drugs, creating investment opportunities for both established and new pharmaceutical companies.

Government Support and Initiatives

The Indian government has introduced several initiatives to support the pharmaceutical sector. One key program, the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, aims to make medicines more affordable and accessible to the public.

Foreign Investment

India is attracting substantial foreign direct investment (FDI) in the pharma sector. The government allows up to 100% foreign direct investment (FDI) in new pharmaceutical projects, which helps boost the sector’s growth.

Install the Tickertape app and enjoy a more hands-on investing experience
  • portfolio-iconReceive real-time market alerts for timely decisions
  • portfolio-iconMonitor your portfolio from the palm of your hands
  • portfolio-iconWatchlist stocks and mutual funds to stay updated
Download Now

Risks of Investing in Pharmaceutical Stocks

Regulatory Risks

Pharmaceutical companies operate under strict regulations. Changes in government policies, drug approvals, or regulatory frameworks can risk their operations and profitability. Delays in approvals or policy shifts can directly affect their stock performance.

Patent Expirations

Pharmaceutical companies depend on patents to maintain exclusive rights over their drugs. When a patent expires, generic versions enter the market, reducing the original manufacturer’s revenue and market share.

Research and Development Failures

Pharmaceutical companies invest heavily in research and development (R&D). If a new drug fails in clinical trials or doesn’t meet expectations, the company can suffer major financial losses and a decline in stock value.

Price Pressure

Pharmaceutical companies, especially those producing generic drugs, often face price pressure. Governments or insurance companies may impose cost-cutting or price-reduction measures, which can lower profitability.

Competition

The pharmaceutical industry remains extremely competitive, with many companies developing similar treatments. This intense competition can lead to price wars, reduced market share, and falling stock prices.

Factors to Consider Before Investing in Pharmaceutical Stocks

Regulatory Environment

Pharmaceutical companies operate under strict regulations and constant oversight. Investors should assess the regulatory environment in all markets where the company operates, as changes in laws, approvals, or compliance requirements can strongly affect its profitability.

Company’s R&D Pipeline

The strength and depth of a company’s research and development (R&D) pipeline determine its growth potential. Companies with a strong pipeline of innovative drugs or therapies offer better long-term opportunities. Investors should review the company’s R&D success rate and consider how much future revenue could come from new products.

Patent Expiration and Generic Competition

When key drug patents expire, generic versions enter the market and reduce revenue. Investors should check which drugs in the company’s portfolio are nearing patent expiration and evaluate how well the company can manage competition from generics.

Market Demand and Trends

Demand for pharmaceutical stocks depends on market needs, especially for therapeutic areas like oncology, vaccines, and chronic disease treatments. Investors should monitor global health trends and their impact on demand for the company’s products.

Competitive Edge

The pharmaceutical sector remains highly competitive, with many companies offering similar drugs. Investors should assess the company’s market share, competitive advantages, and its ability to maintain or grow in a crowded market.

Global Expansion

Pharmaceutical companies expanding into international markets can access new opportunities and diversify revenue sources. Investors should consider the company’s global footprint and its growth potential in the U.S., Europe, and emerging markets.

Conclusion

India ranks among the world’s top pharmaceutical producers and continues to strengthen its position. Medicine spending in India is projected to grow by 9–12% over the next five years, placing the country among the top 10 nations in global medicine spending. However, investors must consider potential risks such as regulatory challenges, patent expirations, R&D failures, competition, and litigation. Evaluating companies based on their financial health, market position, and growth potential remains crucial before investing.

For an in-depth analysis, investors can use the Tickertape Stock Screener to filter and analyse pharmaceutical companies. The tool offers over 200 filters to help investors make informed decisions using key metrics and performance indicators.

Popular Stock Collections

Popular Mutual Fund Collections

Frequently Asked Questions on Pharmaceutical Stocks

  1. What are pharmaceutical stocks?

    Pharma sector stocks are shares of companies that develop, manufacture, and sell medicines, including prescription drugs, over-the-counter products, and medical devices

  2. Which are the top 5 pharma companies in India?

    As of 11th December 2025, the top 5 pharma companies in India based on market capitalisation are:
    1. Sun Pharmaceutical Industries Ltd
    2. Torrent Pharmaceuticals Ltd
    3. Cipla Ltd
    4. Dr Reddy's Laboratories Ltd
    5. Lupin Ltd

    Disclaimer: The above pharma stock list is for educational purposes only and should not be considered investment advice.

  3. What factors influence the pharma share price?

    Pharma share prices are influenced by various factors, including regulatory changes, patent expirations, market demand for drugs, competition from generic products, company earnings, and developments in research and development (R&D).

  4. Are there risks associated with investing in pharmaceutical stocks?

    Yes, there are several risks, including regulatory hurdles, patent expirations, competition from generics, R&D failures, and legal challenges. These factors can affect a company's financial performance and, in turn, its stock price

  5. Which pharma stocks are under 100 Rs?

    As of 11th December 2025, the pharma stocks under ₹ 100 in India based on market capitalisation are:
    1. Alembic Ltd
    2. Morepen Laboratories Ltd
    3. Shukra Pharmaceuticals Ltd
    4. Syncom Formulations (India) Ltd
    5. Anuh Pharma Ltd

    Disclaimer: The above pharma stock list is for educational purposes only and should not be considered investment advice.

  6. Which pharma stocks are below 200 Rs?

    As of 11th December 2025, the pharma stocks under ₹200 in India based on market capitalisation are:
    1. Piramal Pharma Ltd
    2. Marksans Pharma Ltd
    3. Sun Pharma Advanced Research Co Ltd
    4. Suven Life Sciences Ltd
    5. Alembic Ltd

    Disclaimer: The above pharma stock list is for educational purposes only and should not be considered investment advice.

  7. Are pharma stocks a good investment?

    Whether pharma stocks are a good investment depends on various factors, including the individual company's performance, market conditions, and investor goals. It’s important for investors to conduct thorough research before making a decision.

    Disclaimer: Please note that this is only for informational purposes. Please do your own research or consult your financial advisor before investing.

  8. What is the future of pharma in India?

    The Indian pharmaceutical market is projected to reach $130 bn by 2030, driven by strong domestic growth and global demand. However, Growth will also be influenced by innovations in biosimilars, the government’s support for the industry, and the ability of Indian companies to maintain competitiveness.

    Disclaimer: Please note that this is not a recommendation. Please do your own research or consult your financial advisor before investing.

  9. How to analyse pharma stocks?

    To analyse pharma stocks, investors can use the Tickertape Stock Screener, which offers more than 200 filters based on key financial metrics and performance indicators to filter and analyse pharma companies.

  10. How to get the pharma share price list?

    To explore the latest pharma share prices, you can use the Tickertape Stock Screener to view a list of pharmaceutical stocks, compare their performance, and track price movements in real-time.

Disclaimer: This article is for informational purposes only. The content of the article including securities/investment products mentioned if any, should not in any manner be construed as an investment advice, recommendation, offer, solicitation to buy/hold/sell any securities/investment products. The securities quoted if any, are for illustration only and are not recommendatory. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered financial advisor before investing.

Top MF Collections

Value Funds | Hybrid Mutual Funds | Index Funds | Liquid Mutual Funds | Equity Mutual Funds | Flexi Cap Mutual Funds | Arbitrage Mutual Funds | Equity Smallcap Mutual Funds | Power & Energy Mutual Funds